2017-010 Natural History Study Of The Development Of Type 1 Diabetes (Trialnet TN01) Blood draw to determine if a patient may be a risk factor for patients with a family history of Type 1 Diabetes.

Western Sydney University researchers have led a global team to pioneer a new AI-powered tool to assess the risk of ...

Under the new law, anyone in Montana can legally access drugs that have passed just one phase 1 clinical trial.

The U.S. health secretary said people should have access to experimental therapies including unregulated uses of stem cells.

Los Angeles-based Cedars-Sinai is taking a new approach to innovation — one that blends entrepreneurial speed with the clinical rigor of a major health system. “Our journey really began 18 months ago, ...

Screening can now determine their risk for an ever-growing list of conditions — including ones we can’t do much about.

U.S. research on HIV, tuberculosis, Covid-19, mpox, and other fast-moving epidemics is under threat by a hastily announced ...

A multi-agent tool that generates comprehensive company research reports. The platform uses a pipeline of AI agents to gather, curate, and synthesize information about any company.

Here, we highlighted and discussed the potential impact of various aspects of AI in veterinary clinical practice and biomedical research, proposing this technology as a key tool for addressing ...

Rigorous study design and analytical standards are required to generate reliable findings in healthcare from artificial intelligence (AI) research. One crucial but often overlooked aspect is the ...